EUVIMEDEUVIMED entdecken
Crossref

Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey

Philip H Li, Ruby Pawankar, Bernard Yu-Hor Thong, Jie Shen Fok, Hiroshi Chantaphakul, Michihiro Hide, Ankur Kumar Jindal, Hye-Ryun Kang, Amir Hamzah Abdul Latiff, Rommel Crisenio M Lobo, Sonomjamts Munkhbayarlakh, Dinh Van Nguyen und 3 weitere

The Journal of Allergy and Clinical Immunology: In Practice · 2023-04 · 11 (4) · 1253-1260

DOI: 10.1016/j.jaip.2022.12.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023-04. Verfasst von Philip H Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong. Electronic address…. Hauptthemen laut MEDLINE: Angioedemas, Hereditary. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hereditary angioedema (HAE) is a rare genetic disease with significant morbidity and mortality for which early diagnosis and effective therapy are critical. Many Asia Pacific (AP) countries still lack access to diagnostic tests and evidence-based therapies. Epidemiologic data from the AP is needed to formulate regional guidelines to improve standards of care for HAE. OBJECTIVE: To investigate the estimated minimal prevalence, needs, and potential interventions for the diagnosis and management of HAE in the AP. METHODS: A structured questionnaire was distributed to representative experts from member societies of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology. Patient profiles and the presence of diagnostic facilities or tests, regional and national HAE guidelines, and patient support groups were reported and compared. RESULTS: Completed questionnaires were received from 14 representatives of 12 member countries and territories, representing 46% of the world population. Overall minimal prevalence of HAE in the AP region was 0.02/100,000 population, with significant heterogeneity across different centers. Only one-half and one-third had registered on-demand and prophylactic medications, respectively. Few had patient support groups (58%) or regional guidelines (33%), and their existence was associated with the availability of HAE-specific medications. Availability of C1-inhibitor level testing was associated with a lower age at HAE diagnosis (P = .017). CONCLUSIONS: Hereditary angioedema in the AP differs from that in Western countries. Hereditary angioedema-specific medications were registered in only a minority of countries and territories, but those with patient support groups or regional guidelines were more likely to have better access. Asia Pacific-specific consensus and guidelines are lacking and urgently needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioedemas, HereditaryHumansComplement C1 Inhibitor ProteinSurveys and QuestionnairesPrevalenceConsensusPatients

Stichwörter der Autor:innen

AdvocacyAsia PacificEpidemiologyHereditary angioedemaPrevalence

Substanzen

Complement C1 Inhibitor Protein

Autor:innen und Institutionen

  • Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong. Electronic address: liphilip@hku.hk.
  • Department of Pediatrics, Nippon Medical School, Tokyo, Japan. Electronic address: pawankar.ruby@gmail.com.
  • Department of Rheumatology, Allergy, and Immunology, Tan Tock Seng Hospital, Singapore.
  • Department of Respiratory Medicine, Box Hill Hospital, Eastern Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
  • Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Zitieren

APA

Li, P. H., Pawankar, R., Thong, B. Y., Fok, J. S., Chantaphakul, H., Hide, M., Jindal, A. K., Kang, H. R., Abdul Latiff, A. H., Lobo, R. C. M., Munkhbayarlakh, S., Nguyen, D. V., Shyur, S. D., Zhi, Y., & Maurer, M. (2023). Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey. The Journal of Allergy and Clinical Immunology: In Practice, 11(4), 1253-1260. https://doi.org/10.1016/j.jaip.2022.12.021

Vancouver

Li PH, Pawankar R, Thong BY, Fok JS, Chantaphakul H, Hide M, et al. Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey. The Journal of Allergy and Clinical Immunology: In Practice. 2023;11(4):1253-1260. doi:10.1016/j.jaip.2022.12.021

BibTeX
@article{Li2023,
  author = {Li, Philip H and Pawankar, Ruby and Thong, Bernard Yu-Hor and Fok, Jie Shen and Chantaphakul, Hiroshi and Hide, Michihiro and Jindal, Ankur Kumar and Kang, Hye-Ryun and Abdul Latiff, Amir Hamzah and Lobo, Rommel Crisenio M and Munkhbayarlakh, Sonomjamts and Nguyen, Dinh Van and Shyur, Shyh-Dar and Zhi, Yuxiang and Maurer, Marcus},
  title = {Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2023},
  volume = {11},
  number = {4},
  pages = {1253--1260},
  doi = {10.1016/j.jaip.2022.12.021}
}
Kostenlos starten →